Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt  by Wueest, Stephan et al.
FEBS Letters 584 (2010) 4187–4192journal homepage: www.FEBSLetters .orgFas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing
Akt
Stephan Wueest a,b, Reto A. Rapold a,b, Eugen J. Schoenle a, Daniel Konrad a,b,⇑
aDivision of Pediatric Endocrinology and Diabetology, University Children’s Hospital, CH-8032 Zurich, Switzerland
b Zurich Center for Integrative Human Physiology, University of Zurich, CH-8057 Zurich, Switzerlanda r t i c l e i n f o
Article history:
Received 24 June 2010
Revised 18 August 2010
Accepted 30 August 2010
Available online 7 September 2010
Edited by Laszlo Nagy
Keywords:
Insulin resistance
Fas (CD95)
3T3-L1 adipocytes0014-5793/$36.00  2010 Federation of European Bio
doi:10.1016/j.febslet.2010.08.052
Abbreviations: AFasKO, adipocyte-speciﬁc Fas kno
⇑ Corresponding author at: University Children’s H
Endocrinology and Diabetology, Steinwiesstrasse 75,
Fax: +41 44 266 7983.
E-mail address: daniel.konrad@kispi.uzh.ch (D. Koa b s t r a c t
Fas (CD95) belongs to the superfamily of the tumor necrosis factor (TNF) receptors. Besides its key
role in apoptosis, Fas contributes to non-apoptotic pathways such as cell proliferation and inﬂam-
mation. In 3T3-L1 adipocytes, activation of Fas by Fas ligand decreased insulin-stimulated glucose
uptake, without affecting cell viability. This decrease in glucose uptake was accompanied by reduced
protein expression and diminished phosphorylation of Akt. Similarly, insulin-stimulated glucose
incorporation and protein levels of Akt were increased in isolated adipocytes from Fas deﬁcient
mice when compared to wild-type mice. In conclusion, Fas activation in adipocytes decreases Akt
expression and thereby impairs insulin sensitivity.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Fas (CD95) belongs to the super family of the tumor necrosis
factor (TNF) receptors, and plays a key role in the induction of
apoptosis [1,2]. However, recent studies identiﬁed a novel role
for Fas in non-apoptotic pathways such as cell proliferation and
inﬂammation in several cell lines and tissues, similar to the action
of TNFa. Accordingly, Fas activation was shown to induce secretion
of pro-inﬂammatory cytokines like IL-1a, IL-1b, IL-8 (KC) or MCP-1
[3,4]. Likewise, we previously reported that activation of the Fas
signalling pathway in 3T3-L1 adipocytes increased the production
of pro-inﬂammatory cytokines such as IL-6 and KC, without affect-
ing cell viability [5]. Moreover, FasL-treated 3T3-L1 adipocytes be-
came insulin resistant, as revealed by decreased insulin-stimulated
glucose uptake and increased basal lipolysis [5]. However, the
molecular mechanism involved in FasL-induced reduction in insu-
lin-stimulated glucose uptake in 3T3-L1 adipocytes is not clear,
and the present study seeks to unravel this mechanism. We dem-
onstrate that Fas activation in 3T3-L1 adipocytes reduces Akt/PKB
transcription and expression and diminishes phosphorylation of
Akt (Thr308 and Ser473) as well as of its downstream target
AS160 (Thr642). Moreover, FasL-induced insulin-resistance inchemical Societies. Published by E
ckout; Fas-def, Fas deﬁcient
ospital, Division of Pediatric
CH-8032 Zurich, Switzerland.
nrad).3T3-L1 adipocytes is reversible, and adipocytes isolated from Fas-
deﬁcient (Fas-def) mice show increased insulin-stimulated glucose
incorporation compared to WT adipocytes paralleled by higher
expression levels of Akt.
2. Materials and methods
2.1. Animals
C57BL/6J wild-type and total body Fas-deﬁcient (Fas-def) mice
backcrossed for >10 generations onto this same C57BL/6J inbred
strain background (B6.MRLlpr) were obtained from The Jackson
Laboratory. Adipocyte-speciﬁc Fas knockout (AFasKO) mice were
generated as described [5]. All mice were housed in a speciﬁc path-
ogen-free environment on a 12-hour light-dark cycle and fed a
high fat diet (HFD) (D12331, Research Diets, New Brunswick,
USA). All protocols conformed to the Swiss animal protection laws
and were approved by the Cantonal Veterinary Ofﬁce in Zurich,
Switzerland.
2.2. Fat explants
White adipose tissue (retroperitoneal) was collected from
wild-type and AFasKO mice [5]. Pads were rinsed in DMEM
(4.5 g/L D-glucose, Invitrogen, Basel, Switzerland) containing 0.5%
bovine serum albumin (Merck, Geneva, Switzerland) and minced
into pieces of 2 cm2 size and incubated for an hour at 37 C andlsevier B.V. All rights reserved.
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night with 5 ng/ml FasL at 37 C. After incubation, pads were
washed three times with DMEM, and then incubated with or with-
out 100 nM insulin for 20 min. After washing in PBS, pads were
snap frozen in liquid nitrogen and stored at 80 upon lysis.
2.3. Glucose incorporation into isolated adipocytes and glucose uptake
by 3T3-L1 adipocytes
Adipocyte isolation and glucose incorporation were performed
as described previously [6,7]. Glucose uptake by 3T3-L1 adipocyte
was determined as described [8]. Mature 3T3-L1 adipocytes were
incubated with 2 ng/ml membrane-bound FasL (Upstate, Lake Pla-
cid, NY, USA) for 12 h. For the last 3 h of incubation, cells were
starved in FCS-free medium (DMEM, 5 mM glucose). Thirty min-
utes before glucose uptake, insulin (1 or 100 nM) was added to
the medium as indicated.
2.4. Extraction of plasma membranes
Mature 3T3-L1 adipocytes were homogenised in a buffer con-
taining 20 mM HEPES, 250 mM sucrose, 5 mM NaN3, 1 mM EDTA,
0.2 mM PMSF and a 1:1000 dilution protease inhibitor cocktail
(Sigma). Lysates were centrifuged at 1300g for 10 min at 4 C.
Thereafter, supernatant was centrifuged at 229 000g for 90 min
at 4 C (Kontron Instruments, Schlieren, Switzerland). Pellet was
resuspended in 100 ll homogenization buffer and syringed 25
times (1 ml syringe, 25G5/8).
2.5. Western blotting
Cell lysates and tissue samples were homogenized and Western
blotting was performed as described previously [5]. The following
primary antibodies were used: Anti-phospho-Akt (Thr308), anti-
phospho-Akt (Ser473), anti-Akt (Cell signalling, Beverly, MA,
USA); anti-phospho-AS160, anti-IRS-1, anti-IR, anti-PPARc2 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA); anti-GLUT4 and anti-
GLUT1 (gift from Dr. A. Klip, The Hospital for Sick Children, Toron-
to, ON, Canada); anti-Fas, anti-AS160 and anti-phospho IRS-1 (Ser0 1 100
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Fig. 1. Fas activation impairs insulin-stimulated glucose uptake. (A) Lysates were prepar
LDS–PAGE and immunoblotted with anti-Fas antibody. (B) Mature 3T3-L1 adipocytes we
FasL for 12 h and glucose uptake was determined as outlined in the Section 2. Results are
(C) Mature 3T3-L1 adipocytes were incubated for 12 h with or without 2 ng/m
spectrophotometrically (550–655 nm). Results are the mean ± SEM of three independen307) (Upstate, Lake Placid, NY, USA). Membranes were exposed
in an Image Reader and analyzed with Image Analyzer (FujiFilm,
Dielsdorf, Switzerland).
2.6. RNA extraction and quantitative RT-PCR
Total RNA was extracted using the NucleoSpin Kit
(Macherey-Nagel, Oensingen, Switzerland) and RT-PCR was
performed as described [5]. Akt2 PCR primers Mm00545827_m1
and Mm02026778_g1 were purchased from Applied Biosystems.
2.7. Viability assay
Mature 3T3-L1 adipocytes were incubated for 12 h with 2 ng/ml
FasL. Thereafter, cells were incubated with 0.5 mg/ml 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sig-
ma) for 1 h. Salt was extracted from the cells with DMSO. The
amount of yellow MTT reduced to purple formazan was measured
spectrophotometrically.
2.8. Data analysis
Data are presented as means ± SEM and were analyzed by Stu-
dent’s t test, one sample t test or by analysis of variance (ANOVA)
with a Tukey correction for multiple group comparisons.
3. Results
3.1. Fas (CD95) activation in 3T3-L1 adipocytes reduces insulin-
stimulated glucose uptake
Fas (CD95) receptor is expressed in 3T3-L1 adipocytes as well as
in isolated adipocytes of WT mice, but not in adipocytes of adipo-
cyte-speciﬁc Fas knockout (AFasKO) mice (Fig. 1A). Moreover, incu-
bation of 3T3-L1 adipocytes with 2 ng/ml of membrane-bound
FasL for 12 h decreased insulin-stimulated glucose uptake in 3T3-
L1 adipocytes at different insulin concentrations (1 and 100 nM)
without affecting cell viability, while a concentration of 1 ng/ml
FasL had no effect on glucose uptake (Fig. 1B and C).Co FasL
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Fig. 2. Fas activation down regulates Akt expression. (A) Total lysates of untreated and FasL treated (2 ng/ml for 12 h) 3T3-L1 adipocytes were resolved by LDS–PAGE and
immunoblotted with respective antibodies. Total membrane lysates were used for immunoblotting with GLUT4 and GLUT1 antibody. (B) Expression levels of phosphorylated,
total and the ratio of phosphorylated to total Akt (B) and AS160 (C) was calculated in untreated and FasL treated (12 h) cells. Results are the mean ± SEM of 3–6 independent
experiments. *P < 0.05; **P < 0.01 (one sample t test). (D) mRNA expression of Akt2 in 3T3-L1 adipocytes treated without (open bar) or with (black bars) FasL for 3, 6, and 9 h.
Results are the means ± SEM of three independent experiments. **P < 0.01, ***P < 0.001 vs untreated control (one sample t test). (E) Mature 3T3-L1 adipocytes treated with
5 lg/ml actinomycin D (ActD; Sigma) for various time periods (0, 1.5, 3 and 9 h) were incubated either with (ﬁlled circles) or without (open circles) FasL. mRNA expression of
Akt2 was determined with two different set of primers (shown are results for one primer) and linear regression analysis (dotted line) was performed to calculate t1/2. Results
are the means ± SEM of three independent experiments.
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ling pathway were analyzed next. Incubation of 3T3-L1 adipocytes
with 2 ng/ml FasL for 12 h had no effect on IR, IRS-1, pIRS-1
(Ser307), total AS160, GLUT4 and GLUT1 levels (Fig. 2A and Table
1). However, levels of phosphorylated Akt (Thr308 and Ser473)
as well as of total Akt were signiﬁcantly down regulated upon
Fas activation (Fig. 2A and Table 1). Interestingly, the ratio of phos-
phorylated Akt to total Akt was not affected upon Fas activation,
suggesting that Fas activation reduces primarily Akt expression
and does not directly interfere with insulin signalling upstream
of Akt (Fig. 2B). In order to investigate whether decreased pAkt lev-
els lead to reduced propagation of the insulin signal, phosphoryla-
tion of one of Akt’s downstream target, AS160, was determined.
Indeed, incubation of 3T3-L1 adipocytes with 2 ng/ml FasL for
12 h attenuated phosphorylation of AS160 on Thr642 (Fig. 2Aand Table 1) without affecting total AS160 levels (Fig. 2C), suggest-
ing impaired insulin signalling downstream of Akt. To explore
whether Fas activation affects transcript levels of Akt, mRNA levels
of Akt were determined in untreated and FasL-treated 3T3-L1 adi-
pocytes. Transcript levels of Akt2, the most abundant and for glu-
cose metabolism most important Akt isoform in adipocytes [9],
were signiﬁcantly down regulated upon FasL incubation (Fig. 2D),
demonstrating that Fas activation down regulates Akt expression
on transcriptional level. To investigate whether Fas activation has
an effect on mRNA stability of Akt2, half life time (t1/2) of the mRNA
of untreated and FasL-treated cells was determined. As shown in
Fig. 2E, t1/2 was diminished. However this difference did not reach
statistical signiﬁcance (8.4 ± 1.5 h in untreated vs 5.2 ± 0.6 h in
treated cells; P = 0.12). Hence, although there is a trend to de-
creased mRNA stability upon FasL treatment, these data suggest
Table 1
Fas activation affects protein levels of insulin signalling cascade in 3T3-L1 adipocytes.
Protein Control FasL
IR 1.0 0.99 ± 0.19
IRS-1 1.0 0.82 ± 0.25
pS307 IRS-1 1.0 1.06 ± 0.16
pAkt (Thr308) 1.0 0.52 ± 0.09**
pAkt (Ser473) 1.0 0.63 ± 0.13*
Akt 1.0 0.56 ± 0.07**
pAS160 (Thr642) 1.0 0.34 ± 0.15*
AS160 1.0 0.73 ± 0.3
GLUT1 1.0 0.83 ± 0.07
GLUT4 1.0 0.97 ± 0.15
Values are means ± SEM of 3–10 independent experiments; *P < 0.05, **P < 0.01
(One sample t test).
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Fig. 3. Recovery of Akt restores insulin-stimulated glucose uptake. (A) Mature 3T3-
L1 adipocytes were incubated with (black bars; FasL) or without (open bars; Co)
2 ng/ml FasL for 12 h. Cells were then incubated with normal glucose medium
(DMEM, 5 nM, 2% FCS) without FasL for 9 h (hatched bars; Rev) and 2-deoxyglucose
glucose uptake was determined as outlined in Fig. 1. Results are the mean ± SEM of
three independent experiments. *P < 0.05, **P < 0.01 (ANOVA). (B) Total lysates of
3T3-L1 adipocytes were treated as outlined in Fig. 3A, stimulated with 100 nM
human insulin for 30 min, resolved by LDS–PAGE and immunoblotted with anti-
pAkt (Thr308) or anti-Akt antibody. Results are the mean ± SEM of three indepen-
dent experiments. *P < 0.05 (one sample t test, Student’s t test).
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mRNA transcription.
3.2. Impaired insulin-stimulated glucose uptake into 3T3-L1
adipocytes upon Fas activation is reversible
The similar viability of FasL-treated and untreated cells
(Fig. 1C), as well as the fact that many proteins of the insulin sig-
nalling pathway were not affected by Fas activation (Fig. 2A and
Table 1) suggested that incubation of 3T3-L1 adipocytes with
2 ng/ml FasL for 12 h activated mostly non-apoptotic processes.
To further support this idea, experiments to determine the revers-
ibility of FasL-induced alterations were performed. 3T3-L1 adipo-
cytes were incubated with 2 ng/ml FasL for 12 h; thereafter cells
were washed with PBS, and were recovered in media (DMEM,
5 mM glucose) without FasL for 9 h. Upon recovery, the reduction
in insulin-stimulated glucose uptake was reverted (Fig. 3A), sug-
gesting that 3T3-L1 adipocytes were not determined to apoptosis
after incubation with 2 ng/ml FasL for 12 h. Similarly, phosphoryla-
tion of Akt (Thr308) recovered, accompanied by restoration of total
Akt levels (Fig. 3B).
3.3. Membrane-bound FasL signals via Fas receptor
To check whether the observed effects of FasL treatment on
3T3-L1 adipocytes were speciﬁc to the activation of the Fas recep-
tor and not to (unspeciﬁc) effects, e.g., via activation of the TNF
receptor, experiments were performed in fat explants harvested
from AFasKO mice. As expected, Fas expression was reduced in
white adipose tissue of AFasKOmice compared to WT (Supplemen-
tary Fig. 1). However since Fas is still expressed in the stromal vas-
cular fraction of adipose tissue, Fas is still present in adipose tissue
of AFasKO mice [5], while it is almost completely absent in isolated
adipocytes (Fig. 1A). Whereas incubation of fat explants with FasL
from WT mice decreased Akt phosphorylation (Thr308) (Supple-
mentary Fig. 1), similar to what was observed in 3T3-L1 adipocytes
(Fig. 2A), FasL treatment had no effect on Akt phosphorylation in
fat explants from AFasKO mice (Supplementary Fig. 1). Such data
therefore suggest that the membrane-bound FasL used in this
study signals speciﬁcally via the Fas receptor.
3.4. Akt expression and insulin-stimulated glucose incorporation are
increased in Fas-def adipocytes
To investigate whether Fas activation in adipocytes has an effect
on Akt expression in vivo, expression levels of Akt were analyzed in
isolated adipocytes of WT and Fas-def mice fed a high fat diet
(HFD) for 6 weeks. We previously showed that Fas is up regulated
in adipocytes of WT mice upon 6 weeks of HFD [5]. As shown in
Fig. 4A, deletion of Fas from adipocytes resulted in signiﬁcantly in-creased Akt expression compared to WT adipocytes. In addition,
insulin-stimulated (0.5 and 100 nM) glucose incorporation into
adipocytes isolated from Fas-def mice was preserved (Fig. 4B), sug-
gesting improved insulin sensitivity due to higher Akt levels.
4. Discussion
Fas (CD95), a member of the TNF receptor super family, is a major
contributor to apoptosis in many cells. Findings over the last years,
however, revealed that activation of the Fas signalling pathway can
evoke non-apoptotic responses in different cells, similar to the ac-
tion of TNFa [3–5]. We recently provided evidence that activation
of Fas may contribute to obesity-induced insulin resistance since
mice lacking Fas in adipocytes were partly protected from develop-
ing insulin resistance. In particular, Fas activation led to increased
release of pro-inﬂammatory cytokines, and reduced insulin-stimu-
lated glucose uptake in 3T3-L1 adipocytes [5]. The aim of the pres-
ent study was to further characterize the mechanism involved in
the latter. Here we show that Fas activation in 3T3-L1 adipocytes
decreased Akt mRNA levels by reducing its transcription (Fig. 2D
and E) and, subsequently, protein content. Consequently, reduction
in Akt protein levels led to reduced propagation of the insulin signal
asmanifested by decreased phosphorylation of AS160 albeit its pro-
tein levels were not signiﬁcantly decreased. Similar reduction of to-
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Fig. 4. Akt expression is increased in Fas-def adipocytes. (A) Total cell lysates were prepared from isolated adipocytes of wild-type and Fas-def mice. Lysates were resolved by
LDS–PAGE and immunoblotted with anti-Fas, anti-Akt or anti-actin antibody. Results represent the mean ± SEM of 4–5 experiments. *P < 0.05 (Student’s t test). (B) 14C-D-
glucose incorporation into isolated adipocytes from HFD-fed WT (open bars) and Fas-def (black bars) mice was determined in the absence or presence of insulin as indicated.
Shown are absolute values of glucose incorporation. Results represent the mean ± SEM of six experiments. ***P < 0.001 (Student’s t test).
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stimulation suggests that insulin signalling is not altered upstream
of Akt. Accordingly, levels of IR, IRS-1 and pS307 IRS-1 were not af-
fected by the activation of the Fas signalling pathway in 3T3-L1 adi-
pocytes (Fig. 2A and Table 1).
Similar ﬁndings of reduced Akt levels were reported for the acti-
vation of the TNFa pathway in 3T3-L1 adipocytes [10]. However,
TNFa levels were not increased in the supernatant of 3T3-L1 adipo-
cytes treated for 12 h with FasL (45.2 ± 1.0 pg/ml in untreated vs
47.4 ± 0.7 pg/ml in FasL-treated cells). In addition, we show herein
that membrane-bound FasL signals speciﬁcally via the Fas recep-
tor, as FasL incubation of fat pads harvested from AFasKO mice
had no effect on the phosphorylation of Akt (Supplementary
Fig. 1). Therefore, neither a paracrine TNFa effect nor signalling
of FasL via the TNF receptor is responsible for the observed effects.
Possibly, increased release of cytokines like IL-6 upon Fas activa-
tion contributes to reduced insulin-stimulated glucose uptake in
3T3-L1 adipocytes [5]. However, IL-6 was shown to impair glucose
uptake via down regulation of GLUT4 [11], an effect that we did not
observe in FasL-treated cells (Fig. 2A and Table 1). In addition, FasL-
induced inhibition of glucose uptake could not be reverted using a
neutralizing IL-6 antibody (data not shown). Moreover, Fas activa-
tion induced secretion of IL-6 into the supernatant was only ob-
served after 6 h of incubation (Supplementary Fig. 2), whereas
Akt mRNA was already decreased upon 3 h of FasL incubation
(Fig. 2D). These data suggest that increased IL-6 secretion is not in-
volved in decreased Akt mRNA transcription upon Fas activation.
What could be the mechanism of reduced Akt transcription upon
FasL incubation in 3T3-L1 adipocytes? Fas activation was
previously shown to activate the NF-jB, JNK and ERK signalling
pathways in several cells and therefore to affect transcription
[12]. However, incubation of 3T3-L1 adipocytes with membrane-
bound FasL did neither activate the NF-jB signalling pathway
(Supplementary Fig. 3) nor the JNK pathway (data not shown). In
contrast, incubation of 3T3-L1 adipocytes with 2 ng/ml FasL acti-
vated the ERK signalling pathway. Inhibition of ERK activation with
the MEK inhibitor U0126 during FasL incubation, however, could
not prevent Fas activation induced Akt down regulation (data not
shown). Hence, three presently known transcription pathways in-
duced by Fas activation could be excluded as potential contributors
to the observed effects in 3T3-L1 adipocytes. Akt2 promotor
analysis (www.genecards.org, August 2010) suggests that PPARc
binds to the promotor region of Akt2. Treatment of 3T3-L1
adipocytes with FasL signiﬁcantly reduces PPARc protein levels(Supplementary Fig. 4). Interestingly, increased activation of
PPARc by treatment with rosiglitazone prevented Fas-induced
down regulation of Akt2 mRNA (Supplementary Fig. 4), suggesting
that reduced PPARc levels upon Fas activation might be involved in
reduced Akt2 transcription. Moreover, besides reducing Akt2 tran-
scription, Fas activation might also reduce mRNA stability of Akt2
(Fig. 2E).
Activation of the Fas signalling pathway may contribute to
obesity-induced insulin-resistance of adipocytes [5]. Consistent
with such notion, insulin-stimulated glucose incorporation into
isolated adipocytes from Fas-def mice was increased and paralleled
by enhanced expression of Akt, suggesting that the absence of Fas
prevented adipocytes from Fas-induced down regulation of Akt
and, therefore, decreased insulin sensitivity. In addition, reduced
expression of pro-inﬂammatory cytokines in WAT of Fas-def mice
may have contributed to increased insulin sensitivity of adipo-
cytes. Further studies are needed to unravel this question.
In conclusion, our results suggest that Fas activation in adipo-
cytes decreases Akt expression and, therefore, reduces insulin-
stimulated glucose uptake/incorporation.5. Conﬂict of interest
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